Home › Funds › Boston Common Asset Management, LLC › GILD

Boston Common Asset Management, LLC position in GILD

GILEAD SCIENCES INC · Health Care

Boston Common Asset Management, LLC reported holding 99,047 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$14.8M, representing 0.86% of its reported portfolio and ranking #29 among its reported holdings. Boston Common Asset Management, LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)99.05K sh
Reported value held$14.76M
Portfolio Weight0.86%
First reportedQ3 2023
Last changeAdd
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Boston Common Asset Management, LLC's GILD position evolved

Boston Common Asset Management, LLC first disclosed a stake in GILD in Q3 2023 at 326,347 shares (US$24.5M). Across 13 filings, Boston Common Asset Management, LLC increased the stake 4 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 99,047 shares valued at US$14.8M — an increase of 14,584 shares quarter over quarter.. Notable position changes include a 31% trim in Q4 2024 (shares rose 21% over the following quarter), a 35% trim in Q4 2025 (shares rose 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 326.35K $24.46M New
Q4 2023 264.70K $21.44M Reduce
Q1 2024 233.21K $17.08M Reduce
Q2 2024 183.45K $12.59M Reduce
Q3 2024 169.28K $14.19M Reduce
Q4 2024 115.98K $10.71M Reduce
Q1 2025 133.13K $14.92M Add
Q2 2025 122.08K $13.54M Reduce
Q3 2025 129.69K $14.40M Add
Q4 2025 84.48K $10.37M Reduce
Q1 2026 77.24K $10.77M Reduce
Q2 2026 84.46K $10.67M Add
Q3 2026 99.05K $14.76M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Boston Common Asset Management, LLC held GILD?

Boston Common Asset Management, LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Boston Common Asset Management, LLC's current position in GILD?

As of Q3 2026, Boston Common Asset Management, LLC holds 99.05K shares of GILD (GILEAD SCIENCES INC), valued at $14.76M, representing 0.86% of its reported portfolio and ranking #29.

Has Boston Common Asset Management, LLC been buying or selling GILD?

In the latest 13F filing (Q3 2026), Boston Common Asset Management, LLC increased its position in GILD.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.